Relationship of Early Physician Follow-up and 30-Day Readmission after NSTEMI Among Older Patients
description
Transcript of Relationship of Early Physician Follow-up and 30-Day Readmission after NSTEMI Among Older Patients
Connie N. Hess, MD, Bimal R. Shah, MD, MBA, S. Andrew Peng, MS, Laine Thomas, PhD, Matthew T. Roe, MD, MHS, Eric D. Peterson, MD, MPH
Relationship of Early Physician Follow-up and 30-Day Readmission after NSTEMI Among Older Patients
Disclosures
C.N. Hess: None. S. Peng: None. L. Thomas: None. M.T. Roe: Bristol Myers Squibb, Eli Lilly, Hoffmann-La Roche, Novartis. Astrazeneca, Helsinn Pharmaceuticals, KAI Pharmaceuticals, Merck & Co., Sanofi-Aventis, Orexigen, Regeneron. B.R. Shah: None. E.D. Peterson: Eli Lilly, Janssen Pharmaceuticals.
Background
Strategies to reduce readmissions have focused on transitions of care processes.
Prior data suggest that early physician follow-up after hospitalization for heart failure may reduce readmissions.1
Whether this strategy is effective for acute myocardial infarction (AMI) patients is unknown.
1Hernandez, AF et al. JAMA. 2010;303:1716-1722
Objectives
To characterize hospital variation in early physician follow-up after discharge for non-ST-segment elevation myocardial infarction (NSTEMI)
To examine the relationship between rates of early physician follow-up and risk of readmission
Methods: Data sources and study population Clinical data from CRUSADE registry linked with longitudinal Medicare
claims data from 2003-2006
NSTEMI pts ≥65 years surviving to hospital discharge (n= 42,568)
Patients discharged home (n= 31,789)
• Transfer to acute care facility (n= 4,474)• Transfer to skilled nursing facility/hospice (n= 6,305)
Analysis population: n= 27,852 patients at 228 sites
• Non-index admissions (n= 949)• Hospitals w/o PCI & CABG (n= 3,849)• Hospitals with < 25 pts remaining (n= 927)
Methods: Definitions and outcome
Early physician follow-up MD visit within 7 days of discharge
Primary outcome: 30-day all-cause readmission
Methods: Statistical analyses
Logistic regression with hospital as random effect to examine hospital-level early follow-up and 30-day readmission
Adjustment models:1) Patient demographic and clinical characteristics
2) #1 + hospital features (bed size, region, academic status)
3) #2 + treatment features (discharge medications, revascularization)
Variation in hospital-level early physician follow-up
0-5% 6-10% 11-15% 16-20% 21-25% 26-30% 31-35% 36-40% 41-45% 46-50% 51-55%0
10
20
30
40
50
60Median 23.3% (IQR 17.1%-29.1%)
Hospital early physician follow-up
Num
ber o
f hos
pita
ls
Results: Patient characteristicsHospital Q1
(n=6129)Hospital Q2
(n=6759)Hospital Q3
(n=7626)Hospital Q4
(n=5358)Hospital early follow-up (%) <17.8 17.8-23.2 23.3-28.9 >28.9Demographics
Age, median, y 76.0 76.0 76.0 77.0Female sex (%) 43.7 44.3 44.8 43.9Race (%)
White 89.2 87.8 82.5 83.6Black 6.1 7.3 8.5 8.3
Clinical characteristicsDiabetes Mellitus 33.4 33.2 34.5 35.5Prior MI 28.4 30.0 31.8 31.6Renal insufficiency 14.0 14.9 15.6 16.2Signs of heart failure (%) 25.8 24.3 25.3 28.0Transfer-in status (%) 31.0 31.1 24.1 15.3
In-hospital treatmentCardiac cath (%) 78.0 77.6 75.0 73.8PCI (%) 46.1 45.2 44 43.6CABG (%) 12.1 10.8 10 9.8
Hospital characteristics
Hospital Q1 (n=57)
Hospital Q2 (n=57)
Hospital Q3 (n=57)
Hospital Q4 (n=57)
RegionNortheast (%)
South (%)Midwest (%)
West (%)
22.836.836.81.8
28.131.633.37.0
17.535.128.119.3
17.524.638.615.8
Teaching hospital (%) 22.8 38.6 26.3 31.6Median # hospital beds 374.0 431.0 352.0 391.0Median length of stay (days) 5.3 5.3 5.4 5.5Transfer-in patients (%) 12.1 10.8 10 9.8
Unadjusted 30-day readmission by hospital-level early physician follow-up
Overall Hospital Q1 Hospital Q2 Hospital Q3 Hospital Q415
16
17
18
19
20
18.5118.73
17.9418.13
19.51
30-d
ay re
adm
issi
on (%
) p = 0.13
0.4 0.6 0.8 1 1.2 1.4 1.6
Model 1Quartile 2Quartile 3Quartile 4
Model 2Quartile 2Quartile 3Quartile 4
Model 3Quartile 2Quartile 3Quartile 4
Adjusted 30-day readmission by hospital-level early physician follow-up
Study limitations
Observational study - residual confounding No data regarding non-physician post-
discharge medical contacts Limited to follow-up w/in 7 days and
readmission w/in 30 days Hospital-level measure insensitive
Low overall rates of early follow-up
Conclusions
1 in 5 older NSTEMI patient readmitted within 30 days of discharge
Most patients not seen in follow-up by a physician within 7 days of discharge
Overall hospital rate of early physician follow-up low but variable
No association between early physician follow-up and 30-day readmission demonstrated
Future directions
Prospective assessment of early physician follow-up and readmission
Examination of other strategies to reduce readmission after AMI
Effectiveness of early follow-up as part of bundled strategy rather than isolated intervention
Thank you